G. Kramer

2.7k citations

23 papers · 1.8k indexed · 2 hit papers · h-index 11

Impact in

Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Oncology top 2%
- Lung Cancer Research Studies

Papers in

Otorhinolaryngology 3
- Head and Neck Cancer Studies 3
Pulmonary and Respiratory Medicine 22
- Lung Cancer Treatments and Mutations 17
- Lung Cancer Diagnosis and Treatment 15
- Brain Metastases and Treatment 5

Co-authors: Corinne Faivre‐Finn Laurence Collette M. Hatton Suresh Senan Ben J. Slotman Elaine M. Rankin Pieter E. Postmus M. Snee
Journals: Lung Cancer (8 papers)Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Clinical Lung Cancer (1 paper)
Partner nations: Netherlands Belgium United Kingdom

In The Last Decade

G. Kramer

23 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer 2007 · 711 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 New England Journal of Medicine
2007 JNCI Journal of the National Cancer Institute

Peers

Countries citing papers authored by G. Kramer

Since Specialization

Citations

This map shows the geographic impact of G. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Kramer more than expected).

Fields of papers citing papers by G. Kramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Kramer. The network helps show where G. Kramer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Kramer Line = papers co-authored together G. Kramer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neuro-cognitive follow-up among patients with limited small cell cancer (SCLC) treated with two different doses of prophylactic cranial irradiation (PCI) according to the intergroup phase III trial (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212) Pure Amsterdam UMC ·C. Le Péchoux, A. Laplanche, 和夫三宅, Tudor–Eliade Ciuleanu, Rinus Wanders, G. Kramer, D. Lerouge, M. Hatton, Gregory M.M. Videtic, Ariane Dunant, Suresh Senan, Aaron H. Wolfson	2009	3
2	Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups Journal of Clinical Oncology ·Ben J. Slotman, Murielle Mauer, Andrew Bottomley, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Pieter E. Postmus, Laurence Collette, Suresh Senan	2008	164
3	[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. PubMed ·Ben J. Slotman, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Pieter E. Postmus, Laurence Collette, E. Musat, Suresh Senan	2008	2
4	Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer JNCI Journal of the National Cancer Institute ·Jan P. van Meerbeeck, G. Kramer, Paul Van Schil, Cathérine Legrand, Egbert F. Smit, Franz M.N.H. Schramel, Vivianne C. G. Tjan‐Heijnen, Bonne Biesma, C. Debruyne, Nico van Zandwijk, Ted A.W. Splinter, Giuseppe Giaccone Hit paper breakdown →	2007	471
5	Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer New England Journal of Medicine ·Ben J. Slotman, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Pieter E. Postmus, Laurence Collette, E. Musat, Suresh Senan Hit paper breakdown →	2007	711
6	Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993) International Journal of Radiation OncologyBiologyPhysics ·Ben J. Slotman, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, Luen Maraucci Rubião Ardenghi, M. Hatton, Pieter E. Postmus, Laurence Collette, Murielle Mauer, Suresh Senan	2007	16
7	A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993–22993) Journal of Clinical Oncology ·Ben J. Slotman, Corinne Faivre‐Finn, G. Kramer, Elaine M. Rankin, M. Snee, M. Hatton, Gaetan de Schaetzen, Laurence Collette, Suresh Senan	2007	9
8	Does downstaging in patients (pts) with IIIA-N2 non-small cell lung cancer (NSCLC) and a response to induction chemotherapy (ICT) influence outcome with surgery (S) or radiotherapy (RT)? An exploratory analysis of EORTC 08941 Journal of Clinical Oncology ·Jan P. van Meerbeeck, G. Kramer, Catherine Legrand, Egbert F. Smit, A. Passioukov, Giuseppe Giaccone, Nico van Zandwijk, Paul E. Van Schil	2006	3
9	Morbidity and mortality in the surgery arm of EORTC 08941 trial European Respiratory Journal ·Stacytabi Deepal, Jan P. van Meerbeeck, G. Kramer, Ted A.W. Splinter, Catherine Legrand, Giuseppe Giaccone, C. Manegold, Nico van Zandwijk	2005	66
10	A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941) Journal of Clinical Oncology ·Jan P. van Meerbeeck, G. Kramer, Paul E. Van Schil, Catherine Legrand, Egbert F. Smit, 正継長野, Bonne Biesma, Vivianne C. G. Tjan‐Heijnen, Nico van Zandwijk, Giuseppe Giaccone	2005	41
11	Pr5 A randomized trial of radical surgery (S) versus thoracicradiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941) Lung Cancer ·Raduã Ramon Tesch Cataneo, Paul Van Schil, G. Kramer, Catherine Legrand, E O’Brien, C. Manegold, A. Passioukov, Giuseppe Giaccone, Nico van Zandwijk, Ted A.W. Splinter	2005	5
12	Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study Lung Cancer ·J.M. de Rijke, Leo J. Schouten, G.P.M. ten Velde, S. Wanders, E.C.M. Bollen, Roy Lalisang, J.A.A.M. van Dijck, G. Kramer, Piet A. van den Brandt	2004	74
13	O-273 Induction chemotherapy (CT) in stage IIIA-N2 non-small cell lung cancer (NSCLC): An analysis of different regimens used in EORTC 08941 Lung Cancer ·Jan P. van Meerbeeck, G. Kramer, Paul Van Schil, Catherine Legrand, Mary O’Brien, Christian Manegold, Giuseppe Giaccone, Nico van Zandwijk, Ted A.W. Splinter	2003	6
14	O-147 Surgery after induction chemotherapy: Morbidity and mortality in the first 100 patients of the surgery arm of EORTC 08941 trial Lung Cancer ·Paul E. Van Schil, Jan P. van Meerbeeck, G. Kramer, Ted A.W. Splinter, Catherine Legrand, Mary O’Brien, Giuseppe Giaccone, C. Manegold, Nico van Zandwijk	2003	3
15	Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989–1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands Lung Cancer ·J.A.A.M. van Dijck, Jan Festen, Frederick Braimah, G. Kramer, Vivianne C. G. Tjan‐Heijnen, André L. M. Verbeek	2001	5
16	Randomized Trial of Surgery Versus Radiotherapy in Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer After a Response to Induction Chemotherapy: EORTC 08941 Clinical Lung Cancer ·Ted A.W. Splinter, Paul E. Van Schil, G. Kramer, Jan P. van Meerbeeck, A. Gregor, P Rocmans, A. Kirkpatrick	2000	21
17	Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin’s disease treated with 90yttrium-silicate Lung Cancer ·G. Kramer, Stephen L. Gans, A. Rijnders, J.W.H. Leer	2000	10
18	Gemcitabine and Cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 Non-Small Cell Lung Cancer: A phase II study of the EORTC Lung Cancer Cooperative Group (EORTC 08955) Lung Cancer ·Nico van Zandwijk, Chia-Chun Liu, G. Kramer, Franz M.N.H. Schramel, Steven Gans, Jan Festen, A. Termeer, N.J.J. Schlösser, C. Debruyne, Desmond Curran, Giuseppe Giaccone	2000	4
19	Subcutaneous sacrococcygeal ependymoma with inguinal lymph node metastastis Journal of neurosurgery ·G. Kramer, E.H.J.M. Rutten, Raúl N. Rapela	1988	35
20	Evaluation of short-course preoperative irradiation in the treatment of resectable bronchus carcinoma: long-term analysis of a randomized pilot-study International Journal of Radiation OncologyBiologyPhysics ·Ismail Kazem, B. Carter, L.K. Lacquet, G. Kramer, P.L.M. Huygen	1984	4

About G. Kramer

G. Kramer is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (11 papers), Brain Metastases and Treatment (5 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Head and Neck Cancer Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Oncology (1.2k citations), Otorhinolaryngology (110 citations), Epidemiology (558 citations) and Genetics (156 citations). G. Kramer has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Corinne Faivre‐Finn, Laurence Collette, M. Hatton, Suresh Senan, Ben J. Slotman, Elaine M. Rankin, Pieter E. Postmus, M. Snee, E. Musat and Nico van Zandwijk. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, JNCI Journal of the National Cancer Institute and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact